SCHEMBL28116880

SCHEMBL28116880

CCOC(C)OC1COCCO1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863382 0.85
SCHEMBL13641574 0.78 CHRM2 (0.33) CHRM2CHRM4CHRM5CHRM3
SCHEMBL9413711 0.76 LMNA (0.39) LMNA
SCHEMBL5064655 0.75 CHRM2 (0.31) CHRM2CHRM4CHRM5CHRM3
SCHEMBL3871855 0.72
SCHEMBL8631552 0.71 TSHR (0.38) LMNA
Dioxane SCHEMBL7672675 0.71 LMNA (0.67) LMNA
SCHEMBL1107592 0.71 LMNA (0.46) LMNA
SCHEMBL7590839 0.69 LMNA (0.55) LMNA
SCHEMBL15422679 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104530063-B Quinazoline and heterocyclic ring compounds, preparing method of compounds, and application of compounds serving as epidermal growth factor receptor inhibitors used for treating cancer 北京赛特明强医药科技有限公司 2017-01-18 CN disclosed